Disruption of the Gene for CYP1A2, Which is Expressed Primarily in Liver, Leads to Differential Regulation of Hepatic and Pulmonary Mouse CYP1A1 Expression and Augmented Human CYP1A1 Transcriptional Activation in Response to 3-methylcholanthrene In...
Overview
Authors
Affiliations
The cytochrome P4501A (CYP1A) enzymes play important roles in the metabolic activation and detoxification of numerous environmental carcinogens, including polycyclic aromatic hydrocarbons (PAHs). In this study, we tested the hypothesis that hepatic CYP1A2 differentially regulates mouse hepatic and pulmonary CYP1A1 expression and suppresses transcriptional activation of human CYP1A1 (hCYP1A1) promoter in response to 3-methylcholanthrene (MC) in vivo. Administration of wild-type (WT) (C57BL/6J) or Cyp1a2-null mice with a single dose of MC (100 μmol/kg i.p.) caused significant increases in hepatic CYP1A1/1A2 activities, apoprotein content, and mRNA levels 1 day after carcinogen withdrawal compared with vehicle-treated controls. The induction persisted in the WT, but not Cyp1a2-null, animals, for up to 15 days. In the lung, MC caused persistent CYP1A1 induction for up to 8 days in both genotypes, with Cyp1a2-null mice displaying a greater extent of CYP1A1 expression. It is noteworthy that MC caused significant augmentation of human CYP1A1 promoter activation in transgenic mice expressing the hCYP1A1 and the reporter luciferase gene on a Cyp1a2-null background, compared with transgenic mice on the WT background. In contrast, the mouse endogenous hepatic, but not pulmonary, persistent CYP1A1 expression was repressed by MC in the hCYP1A1-Cyp1a2-null mice. Liquid chromatography-mass spectrometry experiments showed that CYP1A2 catalyzed the formation of 1-hydroxy-3-MC and/or 2-hydroxy-3-MC, a metabolite that may contribute to the regulation of CYP1A1 expression. In conclusion, the results suggest that CYP1A2 plays a pivotal role in the regulation of hepatic and pulmonary CYP1A1 by PAHs, a phenomenon that potentially has important implications for PAH-mediated carcinogenesis.
Repurposing antifungal drugs for cancer therapy.
Weng N, Zhang Z, Tan Y, Zhang X, Wei X, Zhu Q J Adv Res. 2022; 48:259-273.
PMID: 36067975 PMC: 10248799. DOI: 10.1016/j.jare.2022.08.018.
Gastelum G, Jiang W, Wang L, Zhou G, Borkar R, Putluri N Toxicol Sci. 2020; 177(2):347-361.
PMID: 32726451 PMC: 7818899. DOI: 10.1093/toxsci/kfaa107.
The reproductive inhibitory effects of levonorgestrel, quinestrol, and EP-1 in Brandt's vole ().
Shi L, Li X, Ji Z, Wang Z, Shi Y, Tian X PeerJ. 2020; 8:e9140.
PMID: 32566388 PMC: 7293854. DOI: 10.7717/peerj.9140.
The Multifarious Link between Cytochrome P450s and Cancer.
Alzahrani A, Rajendran P Oxid Med Cell Longev. 2020; 2020:3028387.
PMID: 31998435 PMC: 6964729. DOI: 10.1155/2020/3028387.
Maturu P, Wei-Liang Y, Jiang W, Wang L, Lingappan K, Barrios R Toxicol Sci. 2017; 157(1):260-271.
PMID: 28201809 PMC: 5837454. DOI: 10.1093/toxsci/kfx036.